Open the mobile version, with barcode scanning
Class II Terminated

Amphotericin B Liposome for Injection, 50mg/vial, Rx only, Distributed by Sun Pharmaceutical Industries, Inc.

Why: Subpotent drug

Company
SUN PHARMACEUTICAL INDUSTRIES INC
Princeton, NJ, United States
Reported
Jul 5, 2023
Recall started
May 30, 2023
Ended
Dec 18, 2023
Where sold
USA nationwide
Amount
12960 vials
Full product description
Amphotericin B Liposome for Injection, 50mg/vial, Rx only, Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti, Halol-389350, Gujarat, India, NDC 62756-0233-01
Lots / codes affected
Lot # BAD0089A, Exp 01/2025; BAD0330A, Exp 07/2025

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.